Peps
What is Nesfatin-1?
Nesfatin-1 is a NUCB2-derived peptide investigated in feeding regulation. Its foundational evidence involved central administration and signaling experiments in rats.
Biological role or research focus
Central feeding regulation.
Brain-administered animal results cannot establish effectiveness or exposure after peripheral administration in humans.
Role reference: Identification of nesfatin-1 as a satiety molecule in the hypothalamus. · 2006 ↗
Names you may encounter
NUCB2-derived nesfatin-1
Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.
- Class / identity
- NUCB2-derived peptide fragment
- Research focus
- Central feeding regulation
- Featured evidence
- Animal study
- Source check
- October 4, 2026
Source: Identification of nesfatin-1 as a satiety molecule in the hypothalamus. · 2006 ↗
Biology & proposed mechanism
The study connected the fragment to hypothalamic feeding circuits and melanocortin-associated responses. Direct administration into the brain is not equivalent to other routes.
Source: Identification of nesfatin-1 as a satiety molecule in the hypothalamus. · 2006 ↗
Research context & identity
This page covers animal neuroendocrine research. It does not establish a clinically effective human weight-loss product.
Source: Identification of nesfatin-1 as a satiety molecule in the hypothalamus. · 2006 ↗
What does the evidence show?
Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.
Animal study · 2006
Discovery of nesfatin-related satiety signaling
What did this publication test, and what did it find?
- Population / model
- Rats used in central feeding-regulation experiments.
- Study design
- Identification of hypothalamic NUCB2-related signaling followed by acute and repeated central administration experiments.
- Main finding
- Central administration reduced food intake, and repeated administration changed weight-related measures in the experimental setting.
- Limits & context
- Brain-administered animal results cannot establish effectiveness or exposure after peripheral administration in humans.
Source: Identification of nesfatin-1 as a satiety molecule in the hypothalamus. · 2006 ↗
Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.
Further reading · 4 additional publication links
Exact-name PubMed search checked 2026-10-04. These records have not been appraised. A name match can include related compounds, combinations, or other formulations; it does not establish safety or benefit.
Nesfatin-1 enhances vascular smooth muscle calcification through facilitating BMP-2 osteogenic signaling. ↗
Cell communication and signaling : CCS · 2024 Oct 11 · Journal Article, Research Support, Non-U.S. Gov't
Read available full text ↗
Nucleobindin-2/Nesfatin-1-A New Cancer Related Molecule? ↗
International journal of molecular sciences · 2021 Aug 2 · Journal Article, Review
Read available full text ↗
New developments on NUCB2/nesfatin-1. ↗
Current pharmaceutical design · 2013 · Editorial, Introductory Journal Article
Multi-functional peptide hormone NUCB2/nesfatin-1. ↗
Endocrine · 2013 Oct · Journal Article, Review
New editorial updates
New source discoveries
Links appear automatically. Unreviewed discoveries are not verified medical findings.
Safety & precautions
Safety & what remains unknown
The central experimental route and animal follow-up cannot define safe human use.
Source: Identification of nesfatin-1 as a satiety molecule in the hypothalamus. · 2006 ↗
Evidence boundaries
Brain-administered animal results cannot establish effectiveness or exposure after peripheral administration in humans.
Source: Identification of nesfatin-1 as a satiety molecule in the hypothalamus. · 2006 ↗
This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.
What are people discussing?
No editorial transcript note has been reviewed for this profile yet. Below are the matching video records available for exploration; title and caption matches are not verified claims.
Watch the source discussions
0 matching video records · 0 with captions indexed.
Across the full library, 30 caption files are indexed from 20,199 inventoried videos. Most transcripts remain unreviewed. Select a thumbnail or timestamp to watch inside PepsRadar. Thumbnail images load from YouTube.
No matching video has been identified in the current snapshot.
Sources & supplier listings
Listings are grouped by the vendor’s stated identity. Blends and modified derivatives are labeled separately. Inclusion is not a quality assessment or an endorsement.
We have not added a supplier for this profile. Missing products and coded listings are not filled with guesses.
Catalog checked 2026-10-04. Seller listings retain their stated intended use. Shops covered: BioLongevity Labs, BioLongevity Supplements, American Peptides, PSPeptides. This is not a market-wide comparison. Affiliate participation does not determine evidence or editorial coverage.
Questions worth asking
- Can the rat feeding result be transferred to a research vial?
- What material, population, and route were actually studied?
- Brain-administered animal results cannot establish effectiveness or exposure after peripheral administration in humans.
- What adverse effects, uncertainty, and conflicts of interest does the original source report?
Frequently asked questions
Can the rat feeding result be transferred to a research vial?
No. Identity, route, exposure, and human outcomes require separate evidence.
Source: Identification of nesfatin-1 as a satiety molecule in the hypothalamus. · 2006 ↗
Does the publication verify a supplier’s product?
No. The tested material and a commercial listing need separate identity and batch checks. A research-use disclaimer does not establish clinical suitability.
Source: Identification of nesfatin-1 as a satiety molecule in the hypothalamus. · 2006 ↗
References & editorial record
Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation. Video notes specify which excerpts were reviewed; no full transcripts are published.